- Home
- GNK vs EVMN Comparison
GNK vs EVMN Comparison
Compare GNK & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNK | EVMN |
|---|---|---|
| Founded | 2004 | 2020 |
| Country | United States | United States |
| Employees | N/A | 48 |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 967.7M | 825.5M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | GNK | EVMN |
|---|---|---|
| Price | $24.05 | $23.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $19.00 | ★ $43.88 |
| AVG Volume (30 Days) | 341.8K | ★ 373.8K |
| Earning Date | 05-06-2026 | 06-11-2026 |
| Dividend Yield | ★ 3.90% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $342,054,000.00 | N/A |
| Revenue This Year | $21.15 | N/A |
| Revenue Next Year | $1.41 | N/A |
| P/E Ratio | $111.29 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.66 | $13.89 |
| 52 Week High | $27.25 | $33.20 |
Technical Indicators
Market Signals| Indicator | GNK | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 48.69 | 48.72 |
| Support Level | $22.40 | $21.32 |
| Resistance Level | $24.25 | $25.50 |
| Average True Range (ATR) | 0.86 | 1.34 |
| MACD | -0.23 | 0.14 |
| Stochastic Oscillator | 18.78 | 59.82 |
Price Performance
Historical ComparisonAbout GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.